Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q4 2024 | 80 | $2.42B | +$186M | -$307M | -$121M | MELI, HDB, IBN, FTI, TEAM | 13F-HR | 2/4/2025, 10:51 AM |
Q3 2024 | 77 | $2.55B | +$52.2M | -$198M | -$146M | MELI, FTI, HDB, IBN, HWM | 13F-HR | 10/30/2024, 04:26 PM |
Q2 2024 | 74 | $2.59B | +$200M | -$546M | -$346M | MELI, FTI, HDB, IBN, ASML | 13F-HR | 8/14/2024, 08:37 AM |
Q1 2024 | 76 | $2.9B | +$114M | -$570M | -$455M | MELI, FTI, IBN, TEAM, ASML | 13F-HR | 5/6/2024, 10:11 AM |
Q4 2023 | 74 | $3.11B | +$239M | -$330M | -$91.3M | MELI, FTI, APTV, ALKS, TEAM | 13F-HR | 1/29/2024, 04:43 PM |
Q3 2023 | 75 | $2.98B | +$246M | -$346M | -$100M | FTI, MELI, TEAM, BABA, ALKS | 13F-HR | 10/20/2023, 10:03 AM |
Q2 2023 | 76 | $3.08B | +$101M | -$216M | -$114M | FTI, ALKS, MLCO, IBN, MELI | 13F-HR | 8/11/2023, 11:28 AM |
Q1 2023 | 73 | $3.06B | +$507M | -$281M | +$226M | FTI, MLCO, ALKS, MELI, BABA | 13F-HR | 5/5/2023, 02:06 PM |
Q4 2022 | 75 | $2.55B | +$283M | -$251M | +$31.8M | FTI, IBN, MLCO, APTV, ALKS | 13F-HR | 2/3/2023, 02:00 PM |
Q3 2022 | 77 | $2.22B | +$200M | -$169M | +$30.7M | APTV, IBN, ALKS, MLCO, ASML | 13F-HR | 11/2/2022, 10:33 AM |
Q2 2022 | 79 | $2.36B | +$92.1M | -$275M | -$182M | APTV, IBN, ALKS, TEAM, MLCO | 13F-HR | 8/2/2022, 04:36 PM |
Q1 2022 | 78 | $3.11B | +$121M | -$236M | -$115M | IBN, APTV, TEAM, MLCO, ASML | 13F-HR | 5/12/2022, 04:28 PM |
Q4 2021 | 77 | $3.71B | +$139M | -$272M | -$133M | APTV, TEAM, IBN, MLCO, SE | Restatement | 3/23/2022, 04:34 PM |
Q3 2021 | 75 | $3.72B | +$226M | -$645M | -$418M | IBN, APTV, TEAM, MLCO, SE | 13F-HR | 11/12/2021, 12:50 PM |
Q2 2021 | 77 | $4.13B | +$439M | -$117M | +$322M | TEAM, APTV, IBN, TSM, MLCO | 13F-HR | 8/9/2021, 03:10 PM |
Q1 2021 | 77 | $3.51B | +$491M | -$532M | -$40.9M | MLCO, APTV, IBN, TEAM, TSM | 13F-HR | 5/12/2021, 11:03 AM |
Q4 2020 | 79 | $3.45B | +$574M | -$127M | +$447M | TEAM, MLCO, BABA, APTV, IBN | 13F-HR | 2/10/2021, 09:44 PM |
Q3 2020 | 76 | $2.67B | +$311M | -$138M | +$173M | BABA, TEAM, MLCO, ASML, IBN | 13F-HR | 11/13/2020, 09:01 PM |
Q2 2020 | 75 | $2.27B | +$341M | -$127M | +$214M | BABA, MLCO, ASML, IBN, TEAM | 13F-HR | 7/23/2020, 04:51 PM |
Q1 2020 | 73 | $1.72B | +$25M | -$233M | -$208M | BABA, ASML, IBN, MLCO, MSFT | 13F-HR | 5/4/2020, 04:41 PM |
Q4 2019 | 69 | $2.48B | +$108M | -$153M | -$44.4M | BABA, IBN, MLCO, ASML, HDB | 13F-HR | 2/5/2020, 03:10 PM |
Q3 2019 | 67 | $2.18B | +$107M | -$50.7M | +$56.4M | BABA, IBN, MLCO, ASML, QGEN | 13F-HR | 10/30/2019, 03:37 PM |
Q2 2019 | 70 | $2.26B | +$37M | -$122M | -$85M | IBN, MLCO, BABA, QGEN, HDB | 13F-HR | 8/5/2019, 03:46 PM |
Q1 2019 | 71 | $2.28B | +$138M | -$142M | -$4.25M | MLCO, IBN, BABA, QGEN, HDB | 13F-HR | 5/3/2019, 02:23 PM |
Q4 2018 | 69 | $1.93B | +$190M | -$331M | -$142M | HDB, MLCO, BABA, QGEN, IBN | 13F-HR | 2/6/2019, 02:00 PM |
Q3 2018 | 69 | $2.32B | +$89M | -$123M | -$33.9M | AVGO, BABA, MLCO, HDB, QGEN | 13F-HR | 10/17/2018, 05:50 PM |
Q2 2018 | 71 | $2.37B | +$291M | -$356M | -$65.3M | HDB, AVGO, MLCO, BABA, QGEN | 13F-HR | 7/18/2018, 03:56 PM |
Q1 2018 | 72 | $2.35B | +$199M | -$222M | -$23.5M | HDB, AVGO, MLCO, BABA, ASML | 13F-HR | 4/30/2018, 11:49 AM |
Q4 2017 | 72 | $2.36B | +$279M | -$333M | -$53.5M | HDB, AVGO, BABA, MLCO, ASML | 13F-HR | 1/26/2018, 03:29 PM |
Q3 2017 | 71 | $2.34B | +$39.8M | -$136M | -$95.7M | HDB, BABA, AVGO, AGN, ASML | 13F-HR | 10/30/2017, 04:13 PM |
Q2 2017 | 76 | $2.32B | +$228M | -$268M | -$39.6M | HDB, AGN, AVGO, BABA, QGEN | Restatement | 8/14/2017, 10:20 AM |
Q1 2017 | 76 | $2.23B | +$153M | -$230M | -$76.6M | AVGO, AGN, NXPI, HDB, MBBYF | 13F-HR | 5/9/2017, 08:36 PM |
Q4 2016 | 77 | $2.05B | +$152M | -$234M | -$81.4M | AVGO, NXPI, AGN, HDB, QGEN | 13F-HR | 2/8/2017, 08:05 AM |
Q3 2016 | 78 | $2.2B | +$113M | -$52.9M | +$60.5M | NXPI, AVGO, AGN, HDB, MBBYF | 13F-HR | 10/24/2016, 11:09 AM |
Q2 2016 | 76 | $1.96B | +$305M | -$79M | +$226M | NXPI, AVGO, AGN, MBBYF, HDB | 13F-HR | 7/27/2016, 02:28 PM |
Q1 2016 | 77 | $1.7B | +$306M | -$96.4M | +$209M | NXPI, BIDU, ASML, MBBYF, HDB | 13F-HR | 5/2/2016, 11:07 AM |
Q4 2015 | 72 | $1.51B | +$138M | -$188M | -$49.9M | QGEN, NXPI, BIDU, HDB, ASML | 13F-HR | 2/9/2016, 04:30 PM |
Q3 2015 | 73 | $1.5B | +$54.1M | -$71M | -$16.9M | QGEN, NXPI, HDB, ASML, BIDU | 13F-HR | 11/10/2015, 11:43 AM |
Q2 2015 | 77 | $1.67B | +$73.7M | -$66M | +$7.68M | NXPI, QGEN, BIDU, ASML, ETN | 13F-HR | 8/11/2015, 08:12 AM |
Q1 2015 | 78 | $1.66B | +$142M | -$410M | -$268M | NXPI, QGEN, BIDU, ASML, ETN | 13F-HR | 5/8/2015, 06:55 AM |
Q4 2014 | 79 | $1.85B | +$233M | -$209M | +$23.7M | NXPI, BIDU, QGEN, ASML, DEO | 13F-HR | 2/4/2015, 12:57 PM |
Q3 2014 | 80 | $1.81B | +$117M | -$121M | -$3.81M | NXPI, QGEN, ETN, ASML, DEO | 13F-HR | 11/12/2014, 09:29 AM |
Q2 2014 | 81 | $1.87B | +$262M | -$101M | +$161M | NXPI, DEO, QGEN, ASML, ETN | 13F-HR | 8/12/2014, 10:10 AM |
Q1 2014 | 80 | $1.71B | +$295M | -$78.2M | +$217M | DEO, ASML, ETN, NXPI, QGEN | 13F-HR | 5/15/2014, 01:02 PM |
Q4 2013 | 78 | $1.52B | $0 | $0 | DEO, ASML, QGEN, MR, ADBE | 13F-HR | 2/10/2014, 09:55 AM |